Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 8
Results: 10
Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 738, doi. 10.1016/j.cllc.2024.06.012
- By:
- Publication type:
- Article
Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 732, doi. 10.1016/j.cllc.2024.07.002
- By:
- Publication type:
- Article
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 672, doi. 10.1016/j.cllc.2024.07.012
- By:
- Publication type:
- Article
Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 723, doi. 10.1016/j.cllc.2024.09.005
- By:
- Publication type:
- Article
Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 705, doi. 10.1016/j.cllc.2024.08.017
- By:
- Publication type:
- Article
Understanding the Social Risk Factors That Avert Equitable Lung Cancer Care.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 699, doi. 10.1016/j.cllc.2024.08.011
- By:
- Publication type:
- Article
Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 690, doi. 10.1016/j.cllc.2024.08.005
- By:
- Publication type:
- Article
Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With Chemoradiotherapy.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 683, doi. 10.1016/j.cllc.2024.07.013
- By:
- Publication type:
- Article
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 712, doi. 10.1016/j.cllc.2024.09.001
- By:
- Publication type:
- Article
Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.
- Published in:
- Clinical Lung Cancer, 2024, v. 25, n. 8, p. 661, doi. 10.1016/j.cllc.2024.07.001
- By:
- Publication type:
- Article